HT

Hirotaka Tanaka

Pfizer: 6 patents #863 of 5,153Top 20%
OC Otsuka Pharmaceutical Co.: 2 patents #437 of 1,273Top 35%
EA Evotec Ag: 1 patents #24 of 51Top 50%
UN Unknown: 1 patents #29,356 of 83,584Top 40%
📍 Miyoshi, JP: #276 of 2,464 inventorsTop 15%
Overall (All Time): #495,524 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
11673878 Benzazepine derivatives Keizo Kan, Masatoshi TAKUWA, Hideto FUJIWARA, Hokuto Yamabe, Satoshi MATSUDA +5 more 2023-06-13
10889570 Benzazepine derivatives Keizo Kan, Masatoshi TAKUWA, Hideto FUJIWARA, Hokuto Yamabe, Satoshi MATSUDA +5 more 2021-01-12
8703433 Marker for amyotrophic lateral sclerosis, and use thereof Hideaki Hara, Masamitsu Shimazawa 2014-04-22
8178558 Substituted pyridylmethyl bicycliccarboxyamide compounds Satoshi Nagayama, Yuji Shishido 2012-05-15
8158650 Substituted phenylmethyl bicyclocarboxyamide compounds Koji Ando 2012-04-17
8153651 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same Matthew Cox, Donogh John Roger O'Mahony, Maria de los Angeles Estiarte-Martinez, Tadashi Kawashima, Satoshi Nagayama +3 more 2012-04-10
8134004 Substituted N-bicyclicalkyl bicycliccarboxyamide compounds Tadashi Kawashima, Satoshi Nagayama, Kazunari Nakao 2012-03-13
7915448 Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists Takeshi Hanazawa, Misato Hirano, Tadashi Inoue, Satoshi Nagayama, Kazunari Nakao +1 more 2011-03-29
7622589 Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists Takeshi Hanazawa, Misato Hirano, Tadashi Inoue, Satoshi Nagayama, Kazunari Nakao +1 more 2009-11-24
7566739 Substituted N-sulfonylaminophenylethyl-2-phenoxyacetamide compounds as VR1 receptor antagonists Takeshi Hanazawa, Misato Hirano, Tadashi Inoue, Satoshi Nagayama, Kazunari Nakao +1 more 2009-07-28